BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 11568667)

  • 1. Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review.
    Huang KH; Lin HC; Lin CD; Wu PC
    Medicine (Baltimore); 2023 Jun; 102(23):e33889. PubMed ID: 37335659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-Phenotype Correlations of Pathogenic
    Robijn SMM; Smits JJ; Sezer K; Huygen PLM; Beynon AJ; van Wijk E; Kremer H; de Vrieze E; Lanting CP; Pennings RJE
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of pathogenic mechanisms of COCH mutations, abolished cochlin secretion, and intracellular aggregate formation: genotype-phenotype correlations in DFNA9 deafness and vestibular disorder.
    Bae SH; Robertson NG; Cho HJ; Morton CC; Jung DJ; Baek JI; Choi SY; Lee J; Lee KY; Kim UK
    Hum Mutat; 2014 Dec; 35(12):1506-1513. PubMed ID: 25230692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid factor and hearing loss.
    Ashok Murthy V; Mohan Kumar J
    Indian J Otolaryngol Head Neck Surg; 2012 Dec; 64(4):364-5. PubMed ID: 24294580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune recognition of molds and homology to the inner ear protein, cochlin, in patients with autoimmune inner ear disease.
    Pathak S; Hatam LJ; Bonagura V; Vambutas A
    J Clin Immunol; 2013 Oct; 33(7):1204-15. PubMed ID: 23912888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel COCH mutation associated with autosomal dominant nonsyndromic hearing loss disrupts the structural stability of the vWFA2 domain.
    Cho HJ; Park HJ; Trexler M; Venselaar H; Lee KY; Robertson NG; Baek JI; Kang BS; Morton CC; Vriend G; Patthy L; Kim UK
    J Mol Med (Berl); 2012 Nov; 90(11):1321-1331. PubMed ID: 22610276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.
    Jones SM; Robertson NG; Given S; Giersch AB; Liberman MC; Morton CC
    Hear Res; 2011 Feb; 272(1-2):42-8. PubMed ID: 21073934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in COCH-implications for genotype-phenotype correlations in DFNA9 hearing loss.
    Hildebrand MS; Gandolfo L; Shearer AE; Webster JA; Jensen M; Kimberling WJ; Stephan D; Huygen PL; Smith RJ; Bahlo M
    Laryngoscope; 2010 Dec; 120(12):2489-93. PubMed ID: 21046548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction.
    Robertson NG; Jones SM; Sivakumaran TA; Giersch AB; Jurado SA; Call LM; Miller CE; Maison SF; Liberman MC; Morton CC
    Hum Mol Genet; 2008 Nov; 17(21):3426-34. PubMed ID: 18697796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of autoantibodies to inner ear antigens in sera of patients with systemic diseases.
    Boulassel MR
    Clin Exp Med; 2008 Mar; 8(1):59-60. PubMed ID: 18385942
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
    Su D; Gudas LJ
    Biochem Pharmacol; 2008 Mar; 75(5):1129-60. PubMed ID: 18164278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlin isoforms and their interaction with CTL2 (SLC44A2) in the inner ear.
    Kommareddi PK; Nair TS; Raphael Y; Telian SA; Kim AH; Arts HA; El-Kashlan HK; Carey TE
    J Assoc Res Otolaryngol; 2007 Dec; 8(4):435-46. PubMed ID: 17926100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing loss.
    Tebo AE; Szankasi P; Hillman TA; Litwin CM; Hill HR
    Clin Exp Immunol; 2006 Dec; 146(3):427-32. PubMed ID: 17100761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides.
    Solares CA; Edling AE; Johnson JM; Baek MJ; Hirose K; Hughes GB; Tuohy VK
    J Clin Invest; 2004 Apr; 113(8):1210-7. PubMed ID: 15085200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental autoimmune hearing loss.
    Billings P
    J Clin Invest; 2004 Apr; 113(8):1114-7. PubMed ID: 15085190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to inner ear antigens in Meniere's disease.
    Riente L; Bongiorni F; Nacci A; Migliorini P; Segnini G; Delle Sedie A; Ursino F; Tommasi S; Fattori B
    Clin Exp Immunol; 2004 Jan; 135(1):159-63. PubMed ID: 14678278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COCH5B2 is a target antigen of anti-inner ear antibodies in autoimmune inner ear diseases.
    Boulassel MR; Tomasi JP; Deggouj N; Gersdorff M
    Otol Neurotol; 2001 Sep; 22(5):614-8. PubMed ID: 11568667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases.
    Boulassel MR; Deggouj N; Tomasi JP; Gersdorff M
    Acta Otolaryngol; 2001 Jan; 121(1):28-34. PubMed ID: 11270490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against inner-ear proteins in the sera of patients with inner-ear diseases.
    Suzuki M; Krug MS; Cheng KC; Yazawa Y; Bernstein J; Yoo TJ
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):10-7. PubMed ID: 9104744
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.